[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360623-105":59,"doc-detail-360623-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","polyamine-related-4-gene-prognostic-signature-in-hepatocellular-carcinoma-abstract","Polyamine-related 4-gene prognostic signature in hepatocellular carcinoma - Abstract","","This study explored the biological and clinical roles of polyamine-related genes (PRGs) in hepatocellular carcinoma (HCC) and built a PRG-based prognostic signature to support prognostic assessment and precision therapy guidance. Twenty-two PRGs were retrieved and integrated with transcriptome, clinical, and somatic mutation data from major public cohorts. Consensus clustering defined PRG subtypes, and Cox-based modeling produced and validated a 4-gene signature (KIF20A, SPP1, PON1, SERPINE1). The signature stratified patients by overall survival, reflected immune microenvironment features, predicted therapy responses, and was supported by multi-level expression verification.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/polyamine-related-4-gene-prognostic-signature-in-hepatocellular-carcinoma-abstract/360623/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/polyamine-related-4-gene-prognostic-signature-in-hepatocellular-carcinoma-abstract/360623.png","ImageObject",300,407,{"name":92,"@type":93},"Aran","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of the study on PRGs in HCC?","Question",{"text":113,"@type":114},"To determine how polyamine-related genes affect biological and clinical behavior in HCC and to create a PRG-based prognostic signature for prognosis assessment and precision therapy guidance.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How many PRGs and what datasets were used to build the signature?",{"text":118,"@type":114},"Twenty-two PRGs were retrieved, and transcriptome, clinical, and somatic mutation data were integrated from public resources including TCGA, International Cancer Genome Collaboratory, and GEO.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the 4-gene prognostic signature and what does it do?",{"text":122,"@type":114},"The signature includes KIF20A, SPP1, PON1, and SERPINE1. It stratifies HCC patients into high- and low-risk groups with significantly different overall survival and provides independent prognostic value.",{"name":124,"@type":111,"acceptedAnswer":125},"How did the signature relate to the tumor immune microenvironment and therapy responses?",{"text":126,"@type":114},"The study analyzed immune infiltration using ssGSEA, CIBERSORT, and ESTIMATE, showing distinct immune patterns between risk groups. High-risk patients had higher TP53 mutation rates and were predicted to have poorer therapy responses.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},360623,1791156103,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","®  \n Observational Study   \nPolyamine-related 4-gene prognostic signature in hepatocellular carcinoma  \nWenjie Shi, MDa , Wenxiang Shi, PhDb , Chenjie Qiu, MDc ,*  \n\n| Abstract\u003Cbr>This study aimed to explore the biological and clinical roles of polyamine-related genes (PRGs) in hepatocellular carcinoma (HCC) and to construct a PRG-based prognostic signature for prognostic assessment and precision therapy guidance in HCC. Twentytwo PRGs were retrieved from the Molecular Signatures Database. Transcriptome, clinical, and somatic mutation data of HCC were integrated from The Cancer Genome Atlas, International Cancer Genome Collaboratory, National Omics Data Encyclopedia, and Gene Expression Omnibus. Consensus clustering identified PRG subtypes, and gene set variation analysis screened differentiallyexpressed genes. Univariate Cox, Least Absolute Shrinkage and Selection Operator, and multivariate Cox regression analyses were used to construct a prognostic signature, validated in internal and 4 external cohorts. Immune infiltration was analyzed via single-sample gene set enrichment analysis, CIBERSORT, and ESTIMATE. The signature’s predictive value for chemotherapy, transcatheter arterial chemoembolization, and immunotherapy was assessed with GDSC, tumor immune dysfunction and exclusion and relevant therapy cohorts, and its performance was compared with 4 published HCC signatures. The expression of signature genes was verified at the mRNA, protein, and single-cell levels. Two PRG subtypes were identified in HCC. Cluster A correlated with poor prognosis, high immune infiltration, and low metabolic activity. A 4-gene signature (KIF20A , SPP1 , PON1 , and SERPINE1) was established, effectively stratifying HCC patients into high-and low-risk groups with significantly different overall survival. It was an independent prognostic factor with better predictive performance than published signatures, and the high-risk group had a higher TP53 mutation rate, distinct immune infiltration patterns, and was predicted to have poor therapy responses. The 4 signature genes showed abnormal expression in HCC tissues at multiple levels. This study identified 2 PRG subtypes anda robust 4-gene prognostic signature for HCC, which accurately predicts prognosis, reflects tumor immune microenvironment features, and guides precision therapy selection, highlighting PRGs’ potential as HCC biomarkers and therapeutic targets. |\n| --- |\n| Abbreviations: AFP = alpha fetoprotein, AKT = protein kinase B , AUC = area under the curve, CNV = copy number variation, C-index = concordance index, DEGs = differentially-expressed genes, EMT = epithelial-mesenchymal transition, GEO = Gene Expression Omnibus, GSEA = gene set enrichment analysis, GSVA = gene set variation analysis, HCC = hepatocellular carcinoma, IC = immune cell, KEGG = Kyoto Encyclopedia of Genes and Genomes, KM = Kaplan–Meier, LASSO = Least Absolute Shrinkage and Selection Operator, OS = overall survival, PRGs = polyamine-related genes, ROC = receiver operating characteristic, ssGSEA = single-sample gene set enrichment analysis, TACE = transcatheter arterial chemoembolization, TC = tumor cell, TCGA = The Cancer Genome Atlas, TIDE = tumor immune dysfunction and exclusion, TMB = tumor mutation burden, TME = tumor microenvironment. |\n| Keywords: biomarker, hepatocellular carcinoma, immune infiltration, molecular subtypes, polyamine, prognostic signature |\n\n1. Introduction  \nLiver cancer is a major public health concern worldwide, representing the third leading cause of cancer-related deaths and the seventh most common cancer incidence. [1] In 2020, around 900,000 new cases of liver cancer were diagnosed globally, with approximately 830,000 deaths attributed to the disease. [1,2] Liver cancer rates are highest in Asian countries,  \nwhere it is the fifth most prevalent cancer and the second leading cause of cancer mortality.[3] It is projected that over 1 million individuals will develop liver cancer by 2025.[4] Th","cbCaiqNkcyd6aM5y","https://ap.wps.com/l/cbCaiqNkcyd6aM5y","pdf",11276144,15,"English","# Abstract\n## Study design and data integration\n## Prognostic signature construction and validation\n## Immune infiltration and therapy response analysis\n## Key results and biological verification","[{\"question\":\"What was the main objective of the study on PRGs in HCC?\",\"answer\":\"To determine how polyamine-related genes affect biological and clinical behavior in HCC and to create a PRG-based prognostic signature for prognosis assessment and precision therapy guidance.\"},{\"question\":\"How many PRGs and what datasets were used to build the signature?\",\"answer\":\"Twenty-two PRGs were retrieved, and transcriptome, clinical, and somatic mutation data were integrated from public resources including TCGA, International Cancer Genome Collaboratory, and GEO.\"},{\"question\":\"What is the 4-gene prognostic signature and what does it do?\",\"answer\":\"The signature includes KIF20A, SPP1, PON1, and SERPINE1. It stratifies HCC patients into high- and low-risk groups with significantly different overall survival and provides independent prognostic value.\"},{\"question\":\"How did the signature relate to the tumor immune microenvironment and therapy responses?\",\"answer\":\"The study analyzed immune infiltration using ssGSEA, CIBERSORT, and ESTIMATE, showing distinct immune patterns between risk groups. High-risk patients had higher TP53 mutation rates and were predicted to have poorer therapy responses.\"}]","Polyamine-related 4-gene prognostic signature in hepatocellular carcinoma - Abstract | PDF",1790140763,38,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4907c6e80350ea843f6091d2a04ca298.webp",983,1310,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0814c6f56229bbd96aa25dfb25cbee49.webp",982,1309,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82a7c3e60e5a53a9ebaafa20112ff763.webp",981,1308,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3d88d686e9d6a3243856f3b342a810b.webp",980,1306]